A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

NCT07670884 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

675

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Management of Body Weight

Interventions

DRUG: HRS9531 Tablet
DRUG: HRS9531 Tablet Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.